Related references
Note: Only part of the references are listed.Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects
Md. Mominur Rahman et al.
MOLECULES (2022)
Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives
Mohammad Mominur Rahman et al.
BIOLOGY-BASEL (2022)
Hutchinson-Gilford Progeria Syndrome: An Overview of the Molecular Mechanism, Pathophysiology and Therapeutic Approach
Md Mominur Rahman et al.
CURRENT GENE THERAPY (2021)
Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology
Zuzana Bologna et al.
BIOMOLECULES & THERAPEUTICS (2017)
Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders
Kelan Thomas et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2017)
GPCR-Mediated Signaling of Metabolites
Anna Sofie Husted et al.
CELL METABOLISM (2017)
Gβγ subunits-Different spaces, different faces
Shahriar M. Khan et al.
PHARMACOLOGICAL RESEARCH (2016)
Oral acetylcysteine for neuropsychiatric disorders
Rebecca Racz et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Oxidative stress and cognition amongst adults without dementia or stroke: Implications for mechanistic and therapeutic research in psychiatric disorders
Dwight F. Newton et al.
PSYCHIATRY RESEARCH (2015)
Psychiatric Disorders: Diagnosis to Therapy
John H. Krystal et al.
CELL (2014)
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Olivia Dean et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice
Linan Chen et al.
JOURNAL OF NEUROSCIENCE (2008)
Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells:: A potential adaptive mechanism for dopaminergic neuroprotection
Zhenquan Jia et al.
NEUROCHEMICAL RESEARCH (2008)
What is the role of astrocyte calcium in neurophysiology?
Cendra Agulhon et al.
NEURON (2008)
Subacute H2O2, but not Poly(IC), upregulates dopamine D-2 receptors in retinolic acid differentiated SH-SY5Y neuroblastoma
Annie Larouche et al.
SYNAPSE (2008)
Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study
R Karry et al.
BIOLOGICAL PSYCHIATRY (2004)
Glutathione pathways in the brain
R Dringen et al.
BIOLOGICAL CHEMISTRY (2003)
Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment
B Halliwell
DRUGS & AGING (2001)
Share Paper
